Hirschsprung's disease (ganglionosis of the colon) is a rare but serious congenital disorder that occurs due to the absence of nerve ganglia in the wall of the colon. As a result of this defect, intestinal motility is impaired, which leads to difficulty or complete inability to defecate. This disease usually manifests itself in newborns and can cause multiple complications, including severe intoxication, infectious lesions and even death. Without timely diagnosis and treatment, the condition can significantly worsen, which emphasizes the relevance and need for awareness of Hirschsprung's disease among both doctors and patients and their families.
History of the disease and interesting historical facts
Hirschsprung's disease was first described in 1888 by Danish pathologist Harald Hirschsprung. While studying patients with severe intestinal dysfunction, Hirschsprung noticed the absence of ganglion cells responsible for regulating intestinal motility. This discovery became fundamental in understanding the pathogenesis of the disease and contributed to further study of its mechanisms. In the early 20th century, surgical treatments became increasingly common, but it took several decades to develop effective approaches to diagnosis and surgical intervention. In recent years, the attention of the scientific community has increasingly focused on the genetic aspects of the disease and the possibilities of early diagnosis.
Epidemiology
According to modern research, Hirschsprung's disease occurs in approximately 1 in 5,000 newborns. This disease is more common among boys, who account for about 80% of all cases. In some populations, the frequency of the disease may vary, which is associated with ethnic characteristics and genetic predisposition. It has been established that in families with one case of the disease, the risk of having another child with this pathology increases several times, which indicates the possibility of a hereditary component.
Genetic predisposition to this disease
Studies show that about 30% cases of Hirschsprung disease have a genetic basis, as evidenced by mutations in certain genes. The most important genes involved in the pathogenesis of the disease include RET, EDNRB, ZFHX1B, and others. Mutations in these genes can disrupt the processes of neurogenesis and migration of nerve cells, which leads to the formation of decompensated intestinal function. Children whose parents have been diagnosed with this disease have an increased chance of developing it, and therefore it is important to conduct genetic counseling to determine the risks.
Risk factors for the development of this disease
Risk factors that contribute to the development of Hirschsprung's disease include:
- Genetic predisposition (presence of cases of the disease in the family history)
- Pregnancy pathologies (infections, toxicosis, reflexes)
- Associated developmental anomalies (cardiac anomalies, genetic syndromes)
- Environmental factors (the impact of harmful chemicals on a pregnant woman)
- Parental age (increased risk with later births)
It has been shown that the presence of one or more of these factors can increase the likelihood of developing the disease.
Diagnosis of this disease
Diagnosis of Hirschsprung's disease is based on clinical symptoms and instrumental examination methods. The main symptoms include:
- No bowel movements in the first 48 hours of life
- Stool retention after the first bowel movement
- Bloating
- Vomiting and water-electrolyte imbalance
To confirm the diagnosis, the following laboratory tests are carried out:
- Clinical blood test (determination of anemia, leukocytosis)
- Blood biochemistry (kidney and liver function parameters)
- Coprogram (analysis of feces for the presence of undigested food)
Radiological investigations may include contrast radiography of the colon, which allows visualization of the hypotensive zone. Endoscopy and biopsy may also be performed to confirm the diagnosis at the histological level. Differential diagnosis should be made with other diseases, such as obstructive syndromes and syndromes associated with physical anomalies.
Treatment
Treatment of Hirschsprung's disease requires a multi-stage approach based on the severity of the pathological process. The main areas include:
- General treatment - at the initial stage includes correction of the patient's hydration and nutrition.
- Pharmacological treatment - may include the use of drugs to improve intestinal motility (but only under the supervision of a doctor).
- Surgical treatment - the main method is resection of the affected part of the intestine with subsequent anastomosis.
- Other types of treatment - it is possible to use rehabilitation methods aimed at restoring motor skills and stabilizing the patient's condition after surgery.
Timely surgical intervention is the key to a successful outcome.
List of medications used to treat this disease
There are currently no specific drugs that target Hirschsprung's disease directly. However, the following drugs may be used depending on the clinical situation:
- Glucocorticoids (in the presence of inflammatory processes)
- Antibiotics (for secondary infections)
- Motility stimulants (as prescribed by a doctor)
- Preparations for the correction of electrolyte disturbances
It is important to remember that the use of medications should be carried out exclusively under the supervision of a physician.
Disease monitoring
Monitoring of patients with Hirschsprung disease includes regular examinations and bowel function testing. Key monitoring points include:
- Examinations every 3-6 months during the first year after surgery
- Evaluation of intestinal motor activity and the presence of complications
- Long-term prognosis: Children usually have a good prognosis, but relapses and complications such as colitis or intestinal obstruction are possible.
- Complications may include infection, perforation, and electrolyte imbalances.
Regular monitoring helps to identify and resolve emerging problems in a timely manner.
Age-related features of the disease
Hirschsprung's disease can manifest itself differently depending on the patient's age category:
- Newborns: incidence of clinical symptoms is high, need for early intervention.
- Young children: delays in physical development and frequent intestinal infections may be observed.
- Adolescents: functional disorders and psychological problems associated with the disease are possible.
- Adults: The risk of complications may increase, including the risk of colon cancer.
Age-related characteristics emphasize the importance of an individual approach and long-term rehabilitation.
Questions and Answers
- What are the main symptoms of Hirschsprung's disease? The main symptoms include lack of bowel movements, abdominal distension, vomiting and anemia.
- How is Hirschsprung's disease diagnosed? Diagnosis is based on clinical symptoms, laboratory tests and radiological studies.
- What is the treatment for Hirschsprung's disease? Treatment includes surgical intervention, as well as general and pharmacological methods to correct the condition.
- What is the outlook for patients with Hirschsprung disease? With timely intervention, the prognosis is favorable in most cases, but complications are possible.
- What is the role of genetics in the development of Hirschsprung disease? About 30% cases have a genetic predisposition, including mutations in certain genes.
Dr. Oleg Korzhikov recommends being attentive to possible signs of Hirschsprung's disease in newborns. If you notice that your baby cannot poop during the first 48 hours of life, contact a specialist immediately. In addition, it is important to remember about a healthy lifestyle during pregnancy, minimize risk factors and undergo regular checkups to prevent complications for both mother and child. After all, early diagnosis and proper treatment are the key to a successful recovery.
